Jan 05, 2023 / 06:15PM GMT
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst
Hi. Good afternoon, everyone, and thanks for joining for the first session of our afternoon lineup. We're very pleased to have IDEXX here today, a leading provider of animal health diagnostic products. On stage with me, I have Jay Mazelsky, President and CEO; and we have John Ravis, from Investor Relations in the audience as well.
Questions and Answers:
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research AnalystJay, maybe to start sort of an open-ended question. 2022, definitely a year of transition for the industry coming off of the surge of demand that we saw during the pandemic. I guess as we sit here at the start of 2023, how do you kind of feel about the state of the industry, both from in terms of how vet clinics have adapted to kind of the new way of the world as well as the demand that you're seeing from the pet owners, many of them knew since the pandemic.
Jonathan J. Mazelsky - IDEXX Laboratories, Inc. -
Trustpilot
